The impairment of a rate-limiting FA oxidation enzyme, carnitine palmitoyltransferase 1 (CPT1), and a rate-limiting TG hydrolysis enzyme, lipoprotein lipase (LPL), is also important mechanism in the development of hepatic lipid accumulation and dyslipidemia [6,7]. This evidence concerns the gene LPL and metabolic syndrome.